Photo of Hun Ju Lee

View Scopus Profile

Hun Ju Lee

Assistant Professor

  • 684 Citations
  • 14 h-Index
20062019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Hun Ju Lee is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 16 Similar Profiles
Mantle-Cell Lymphoma Medicine & Life Sciences
Radiotherapy Medicine & Life Sciences
Hodgkin Disease Medicine & Life Sciences
Lymphoma Medicine & Life Sciences
Marginal Zone B-Cell Lymphoma Medicine & Life Sciences
Acute Myeloid Leukemia Medicine & Life Sciences
Survival Medicine & Life Sciences
B-Cell Lymphoma Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2006 2019

1 Citation (Scopus)

ABVD plus rituximab versus ABVD alone for advanced stage, high-risk classical Hodgkin lymphoma: A randomized phase 2 study

Strati, P., Fanale, M. A., Oki, Y., Turturro, F., Fayad, L. E., Bartlett, N. L., Gladstone, D. E., Kasamon, Y. L., Portlock, C. S., Wilson, W. H., Goy, A., Younes, A. & Lee, H. J., Jan 31 2019, In : Haematologica. 104, 2, p. e65-e67

Research output: Contribution to journal › Letter

Hodgkin Disease
Rituximab
2 Citations (Scopus)

A PET Radiomics Model to Predict Refractory Mediastinal Hodgkin Lymphoma

Milgrom, S. A., Elhalawani, H., Lee, J., Wang, Q., Mohamed, A. S. R., Dabaja, B. S., Pinnix, C. C., Gunther, J., Court, L. E., Uppore Kukkillaya, A. R., Fuller, C., Akhtari, M., Aristophanous, M., Mawlawi, O., Chuang, H. H., Sulman, E. P., Lee, H. J., Hagemeister, F. B., Oki, Y., Fanale, M. A. & 1 others, Smith, G. L., Dec 1 2019, In : Scientific reports. 9, 1, 1322.

Research output: Contribution to journal › Article

Open Access
Hodgkin Disease
Glycolysis
Tumor Burden
Mediastinal Diseases
Area Under Curve

A phase II study of carfilzomib in the treatment of relapsed/refractory mantle cell lymphoma

Lee, H. J., Badillo, M., Romaguera, J. & Wang, L., Feb 1 2019, In : British Journal of Haematology. 184, 3, p. 460-462 3 p.

Research output: Contribution to journal › Letter

Mantle-Cell Lymphoma
carfilzomib

Erratum to: Ultra-low-dose radiotherapy for definitive management of ocular adnexal B-cell lymphoma: Low-dose radiotherapy for adnexal b-cell lymphoma (Head & Neck, (2017), 39, 6, (1095-1100), 10.1002/hed.24717)

Pinnix, C. C., Dabaja, B. S., Milgrom, S. A., Smith, G. L., Abou Yehia, Z., Nastoupil, L., Romaguera, J., Turturro, F., Fowler, N., Fayad, L. E., Westin, J. R., Neelapu, S. S., Fanale, M. A., Rodriguez, M. A., Hagemeister, F. B., Lee, H. J., Oki, Y., Wang, L., Samaniego, F., Chi, T. L. & 1 others, Esmaeli, B., May 1 2019, In : Head and Neck. 41, 5, 1 p.

Research output: Contribution to journal › Comment/debate

Open Access
B-Cell Lymphoma
Names
Lymphoma
Neck
Radiotherapy

Favorable outcomes with de-escalated radiation therapy for limited-stage nodular lymphocyte-predominant Hodgkin lymphoma

Pinnix, C. C., Milgrom, S. A., Cheah, C. Y., Gunther, J., Ludmir, E. B., Wogan, C. F., Nastoupil, L., Neelapu, S. S., Westin, J. R., Lee, H. J., Iyer, S. P., Steiner, R. E., Fayad, L. E., Fowler, N., Wang, L., Samaniego, F., Rodriguez, M. A., Rich, A. E., Medeiros, L. J. & Dabaja, B. S., Jan 1 2019, In : Blood Advances. 3, 9, p. 1356-1367 12 p.

Research output: Contribution to journal › Article

Open Access
Hodgkin Disease
Radiotherapy
Disease-Free Survival
Survival Rate
Therapeutics